Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

1,675.00p
   
  • Change Today:
      25.00p
  • 52 Week High: 3,020.00
  • 52 Week Low: 1,366.67
  • Currency: UK Pounds
  • Shares Issued: 5.22m
  • Volume: 25,679
  • Market Cap: £87.52m

Bioventix Overview

Bioventix was founded in 2003 as a biotechnology company specialising in the creation and supply of high-affinity sheep monoclonal antibodies (SMAs) for use in immunodiagnostics. However, the antibody technology laboratory and some of the staff have been based at the same location in Farnham, Surrey, UK since the early 1990s.

1 Day Chart (22-05-2026)

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 9.7% 0.0%
Div Cover 1.0 0.9
Op Mrgn 75.5% 75.2%
ROCE 77.0%  
Latest F'cast
P/E 10.7 11.4
PEG n/a n/a
Pr/Revenue 6.2 6.5
Pr/Book 7.0  
Latest F'cast
Revenue -3.6% -4.7%
PBT -4.8% -6.9%
EPS -6.3% n/a
DPS -3.2% n/a

Bioventix Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-21 10.93 8.12 129.22p 30.7 n/a -7% 105.00p 2.6%
30-Jun-22 11.72 9.28 147.32p 23.4 1.7 +14% 126.00p 3.7%
30-Jun-23 12.82 10.13 160.63p 24.0 2.7 +9% 152.00p 3.9%
30-Jun-24 13.61 10.60 155.12p 28.4 n/a -3% 155.00p 3.5%
30-Jun-25 13.12 10.10 145.27p 18.9 n/a -6% 150.00p 5.5%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Bioventix Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-26 12.50 9.40 136.10p 12.3 n/a n/a 150.00p 0.0%

Copyright © 2026 FactSet Research Systems Inc. All rights reserved.

Bioventix Company Announcements

Holding(s) in Company 18-May-2026 08:45 RNS
Director Dealing 28-Apr-2026 15:45 RNS
Share Options Awarded 20-Apr-2026 11:54 RNS

Bioventix ShareCast News

Director dealings: Bioventix chairman raises stake 13-Apr-2026 ShareCast
Director dealings: Bioventix chairman raises stake 13-Apr-2026 ShareCast
China weakness sees profits fall for Bioventix 27-Oct-2025 ShareCast

Latest Bioventix Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

Bioventix Market Data

Currency UK Pounds
Share Price 1,675.00p
Change Today 25.00p
% Change 1.52 %
52 Week High 3,020.00
52 Week Low 1,366.67
Volume 25,679
Shares Issued 5.22m
Market Cap £87.52m

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
23.47% above the market average23.47% above the market average23.47% above the market average23.47% above the market average23.47% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Price Trend
67.33% below the market average67.33% below the market average67.33% below the market average67.33% below the market average67.33% below the market average
31.82% below the sector average31.82% below the sector average31.82% below the sector average31.82% below the sector average31.82% below the sector average
Income
60.89% above the market average60.89% above the market average60.89% above the market average60.89% above the market average60.89% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
Growth
5.71% below the market average5.71% below the market average5.71% below the market average5.71% below the market average5.71% below the market average
65.52% below the sector average65.52% below the sector average65.52% below the sector average65.52% below the sector average65.52% below the sector average

Bioventix Dividends

  Latest Previous
  Interim 2nd Interim
Ex-Div 09-Apr-26 06-Nov-25
Paid 24-Apr-26 21-Nov-25
Amount 70.00p 80.00p

Trades for 22-May-2026

Time Volume / Share Price
16:35 1 @ 1,650.00p
16:35 0 @ 1,650.00p
16:35 0 @ 1,650.00p
16:35 1 @ 1,650.00p
16:35 0 @ 1,650.00p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
CFO Bruce Hiscock

Top of Page